# Safety Study of Elvucitabine in HIV-1 Subjects

> **NCT00405249** · PHASE2 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 5 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** elvucitabine

## Key facts

- **NCT ID:** NCT00405249
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2009-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405249, "Safety Study of Elvucitabine in HIV-1 Subjects". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00405249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*